Valuation - physician samples - most of the pharmaceuticals ...
Pharmaceutical Manufacturers' Sample Valuation Based on Cost Data: No Malafide Intent, No Extended Tax Assessment Period.
August 17, 2016
Case Laws Central Excise AT
Valuation - physician samples - most of the pharmaceuticals manufacturers were adopting assessable value on the basis of cost data, we are of the view that no malafide intention can be attributed to the assessee so as to invoke the longer period of limitation - AT
View Source